Expression of duck hepatitis A virus type 1 VP3 protein mediated by avian adeno-associated virus and its immunogenicity in ducklings. 2019

A P Wang, and L Liu, and L L Gu, and S Wu, and C M Guo, and Q Feng, and W L Xia, and C Yuan, and S Y Zhu

The avian adeno-associated virus (AAAV) is a replication-defective nonpathogenic virus that has been proved to be useful as a viral vector in gene delivery. In this study, the feasibility of AAAV for transgenic expression of duck hepatitis A virus (DHAV) VP3 structural protein and its ability to induce protective immunity in ducklings was assessed. The recombinant AAAV (rAAAV-VP3) expressing the VP3 protein was prepared by co-infection of Sf9 cells with recombinant baculovirus (rBac-VP3) containing VP3 gene flanked by inverted terminal repeats (ITRs) of AAAV and the other two recombinant baculovirus expressing AAAV functional and structural genes, respectively. The generation of rAAAV-VP3 was demonstrated by electron microscopy, immunofluorescence assay, and western blot analysis. One day old ducklings were inoculated with rAAAV-VP3 or commercial attenuated vaccine and then challenged with DHAV-1 strain SH two weeks post vaccination. Anti-DHAV-1 antibodies were detected in all vaccinated groups by ELISA, and the titers between the rAAAV-VP3 group and the attenuated vaccine group were not statistically significant. Real time RT-PCR analysis showed that the virus copy numbers in the livers of the PBS control group were significantly higher than that of the rAAAV-VP3 and attenuated vaccine groups. In conclusion, we demonstrated that the VP3 expression mediated by rAAAV in ducklings could induce protective immunity against DHAV challenge, and this could be a candidate vaccine for the control of duck viral hepatitis. Keywords: avian adeno-associated virus; duck hepatitis A virus; VP3 gene; immunogenicity.

UI MeSH Term Description Entries
D004371 Hepatitis Virus, Duck Unassigned species, in the family PICORNAVIRIDAE, causing high mortality in ducklings 3 days to 3 weeks old. Duck Hepatitis Virus,Avihepatovirus A,Duck Hepatitis A Virus,Duck Hepatitis A Virus 1,Duck Hepatitis A Virus 2,Duck Hepatitis A Virus 3,Duck Hepatitis Virus 1,Duck Hepatitis Virus 3,Duck Hepatitis Viruses
D004372 Ducks A water bird in the order Anseriformes (subfamily Anatinae (true ducks)) with a broad blunt bill, short legs, webbed feet, and a waddling gait. Duck
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D014613 Vaccines, Attenuated Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity. Attenuated Vaccine,Vaccines, Live, Attenuated,Attenuated Vaccines,Vaccine, Attenuated
D014764 Viral Proteins Proteins found in any species of virus. Gene Products, Viral,Viral Gene Products,Viral Gene Proteins,Viral Protein,Protein, Viral,Proteins, Viral
D014765 Viral Vaccines Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease. Viral Vaccine,Vaccine, Viral,Vaccines, Viral
D019219 Parvovirinae A subfamily of DNA vertebrate viruses, in the family PARVOVIRIDAE. There are three genera: PARVOVIRUS; ERYTHROVIRUS; and DEPENDOVIRUS. Copiparvovirus,Tetraparvovirus,Copiparvoviruses,Tetraparvoviruses
D030781 Organisms, Genetically Modified Organisms whose GENOME has been changed by a GENETIC ENGINEERING technique. Genetically Modified Organisms,Organisms, Transgenic,Transgenic Organisms,GMO Organism,GMO Organisms,Genetically Engineered Organisms,Genetically Modified Organism,Modified Organism, Genetically,Organism, Genetically Modified,Organism, Transgenic,Organisms, Genetically Engineered

Related Publications

A P Wang, and L Liu, and L L Gu, and S Wu, and C M Guo, and Q Feng, and W L Xia, and C Yuan, and S Y Zhu
September 2017, Scientific reports,
A P Wang, and L Liu, and L L Gu, and S Wu, and C M Guo, and Q Feng, and W L Xia, and C Yuan, and S Y Zhu
July 2018, Journal of virological methods,
A P Wang, and L Liu, and L L Gu, and S Wu, and C M Guo, and Q Feng, and W L Xia, and C Yuan, and S Y Zhu
November 2023, Poultry science,
A P Wang, and L Liu, and L L Gu, and S Wu, and C M Guo, and Q Feng, and W L Xia, and C Yuan, and S Y Zhu
August 2019, Avian pathology : journal of the W.V.P.A,
A P Wang, and L Liu, and L L Gu, and S Wu, and C M Guo, and Q Feng, and W L Xia, and C Yuan, and S Y Zhu
January 2014, Acta virologica,
A P Wang, and L Liu, and L L Gu, and S Wu, and C M Guo, and Q Feng, and W L Xia, and C Yuan, and S Y Zhu
December 2019, Poultry science,
A P Wang, and L Liu, and L L Gu, and S Wu, and C M Guo, and Q Feng, and W L Xia, and C Yuan, and S Y Zhu
November 2009, Vaccine,
A P Wang, and L Liu, and L L Gu, and S Wu, and C M Guo, and Q Feng, and W L Xia, and C Yuan, and S Y Zhu
June 2006, Journal of virology,
A P Wang, and L Liu, and L L Gu, and S Wu, and C M Guo, and Q Feng, and W L Xia, and C Yuan, and S Y Zhu
July 1979, The Veterinary record,
A P Wang, and L Liu, and L L Gu, and S Wu, and C M Guo, and Q Feng, and W L Xia, and C Yuan, and S Y Zhu
April 1978, The Veterinary record,
Copied contents to your clipboard!